The Global Stem Cell Manufacturing Market in terms of revenue is expected to reach $16.1Billion by 2025 at a CAGR of 6.10% from 2018 to 2025 as per new market research report titled Global Stem Cell Manufacturing Market(By Types- hematopoietic stem cells, induced pluripotent stem cells, mesenchymal stem cells, and embryonic stem cells. By application- drug discovery & development, allogeneic stem cell therapy, autologous stem cell therapy, and cell &tissue banking. By end-user- healthcare & surgical center, research organization, pharmaceutical companies, and others)– global industry analysis, size, share, growth, trends, and forecast, 2017 – 2025, by Sheer Analytics & Insights Pvt. Ltd.
The rising awareness of positive stem cell preservation, development of genomic analysis techniques and quality control of stem cell preservation and robust demand for cord blood stem cell banking supported the growth of stem cell manufacturing market.
Some factors such as increasing private and public investments along with the providing funds in the stem cell-based development, growing geriatric population, rising rates of bone marrow transplantation are influencing the growth of the stem cell manufacturing market. Furthermore, healthcare infrastructure advancement for the development of stem cell manufacturing types in a developing economy is further expected to make the market more demanding during the forecast period.
In addition to this, North-America is estimated to hold the largest market share of stem cell manufacturing market owing to the various reimbursement set up by the government for providing better healthcare facilities to the patients is one of the important factors which makes the market more demanding in the North-America region. Europe is also following the footstep of North-America as it is forecasted that in the next few years the Europe global stem cell manufacturing market demand will increase owing to their increase in the geriatric population and huge demand for better and precise treatment processes.
In the recent market research reports that were published by Sheer Analytics & Insights, the global stem cell manufacturing market has been segmented based on the types, application, and end-user. Based on the types, the market has been analyzed as hematopoietic stem cells, induced pluripotent stem cells, mesenchymal stem cells, and embryonic stem cells. The major application of stem cell manufacturing market includes drug discovery & development, allogenic stem cell therapy, autologous stem cell therapy, and cell & tissue banking. On the basis of end-user, the market is segmented into healthcare & surgical center, research organization, pharmaceutical companies among others. The market is also further segmented into geographical region North America, Middle East & Africa, Asia-Pacific, and Latin America.
The professor of pathology at the Keck School of medicine of USC Dr. Cheng-Ming Chuong, is also the senior investigator of a study that was published by the Stem Cell Laboratory of the University of Southern California at Los Angeles. He along with his fellow researcher have started to discover a way through which one can grow hair follicles from the skin cells reproduced in vitro in a lab. The funding of this study was majorly provided by the National Institutes of Health and it is also published in the proceedings of the National Academy of Sciences.
Dr. Cheng-Ming Chuong, Professor of Pathology at the Keck School of Medicine, told in an interview that, “Many aging individuals do not grow hair well, because adult cells lose their regenerative ability. But with our new findings, we are able to make adult mouse cells produce hair again."
The major companies in the global stem cell manufacturing market are as follows, Anterogen Co., Becton, Dickinson & Company, Bio-Rad Laboratories, Cellular Dynamics International, Lonza Group, Merk Group, MiltenyiBiotec, Osiris Therapeutics, and Pharmicell,
Global Stem Cell Manufacturing Market: By Types
- Hematopoietic stem cells
- Induced pluripotent stem cells
- Mesenchymal stem cells
- Embryonic stem cells
Global Stem Cell Manufacturing Market: By Application
- Drug discovery & development
- Allogenic stem cell therapy
- Autologous stem cell therapy
- Cell & tissue banking
Global Stem Cell Manufacturing Market: By End- User
- Healthcare & surgical center
- Research organization
- Pharmaceutical companies
- Others
Global Stem Cell Manufacturing Market: By Geography
North America
- The U.S.
- Canada
- Mexico
Europe
- U.K.
- France
- Germany
- Italy
- Rest of Europe
Asia Pacific
- India
- China
- Japan
- Rest of Asia Pacific
The Middle East and Africa
- South Africa
- Rest of the Middle East and Africa
Latin America
- Brazil
- Rest of Latin America
About Sheer Analytics and Insights Private Limited
Sheer Analytics and Insights Pvt. Ltd. is among the leading market research organizations providing the best B2B researches on various niches. Currently servicing 2000+ clients worldwide, our analysts and marketing team are continually tracking global markets having high growth prospect.
Contact info
Contact Number: +913346009199
Email Address: sales@sheeranalyticsandinsights.com
Copyright © 2018 Sheer Analytics and Insights
All Rights Reserved. This document contains highly confidential information and is the sole property of the Company. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of the company.